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The metabolism of high-fructose corn syrup used to sweeten
soda drinks may lead to elevations in uric acid levels. Here we
determined whether soda drinking is associated with
hyperuricemia and, as a potential consequence, reduced
kidney function. At baseline, 15,745 patients in the
Atherosclerosis Risk in Communities Study completed a
dietary questionnaire and had measurements of their serum
creatinine and uric acid. After 3 and 9 years of follow-up,
multivariate odds ratios from logistic regressions for binary
outcome of hyperuricemia and chronic kidney disease (eGFR
less than 60ml/min per 1.73m2) were evaluated. Compared
to participants who drank less, consumption of over one
soda per day was associated with increased odds of prevalent
hyperuricemia and chronic kidney disease. The odds ratio for
chronic kidney disease significantly increased to 2.59 among
participants who drank more than one soda per day and had
a serum uric acid level over 9.0mg/dl. In longitudinal
analyses, however, drinking more than one soda per day was
not associated with hyperuricemia or chronic kidney disease.
Neither preexistent hyperuricemia nor development of
hyperuricemia modified the lack of association between soda
drinking and incident chronic kidney disease. Thus our study
shows that high consumption of sugar-sweetened soda was
associated with prevalent but not incident hyperuricemia and
chronic kidney disease.
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Consumption of high-fructose corn syrup (HFCS) has
increased nearly 2000% over the past three decades and has
paralleled the epidemics of obesity, metabolic syndrome, and
chronic kidney disease (CKD).1 Estimates from the US
Department of Agriculture report the average yearly intake of
HFCS as an added sweetener to be as high as 62.4 pounds per
person. Sweetened beverages such as regular soda account for
over 70% of this intake.2
The metabolism of fructose, unique to that of other
sugars, depletes hepatic adenosine triphosphate, increasing
the degradation of nucleotides and promoting the synthesis
of uric acid.3 Data from the Third National Health and
Nutrition Examination Survey suggested a link between
regular, but not diet, soda consumption and the frequency of
hyperuricemia,4 concerning in the light of recent epidemio-
logical studies in which elevated uric acid levels indepen-
dently increased the risk for incident kidney disease and
progression of established CKD.5–8 In animals, fructose-
associated hyperuricemia produces a metabolic syndrome
associated with glomerular hypertension, renal hyper-
trophy, and arteriolopathy of the renal vasculature, with
resultant reductions in creatinine clearance and increases
in proteinuria.3,9–11
The controversy over the potential dangers of HFCS has
been playing out not only in the medical literature12–17 but
also in the mainstream media, including advertising cam-
paigns funded by the corn-producing industry. Defenders of
HFCS point out that this sweetener comprises, approxi-
mately, 40–55% fructose (the other components being
glucose and polymers of glucose); therefore findings from
animal and human studies that use 100% fructose formula-
tions may not apply to HFCS.18
Two recent investigations have suggested that sugar-
sweetened soda consumption is associated with albuminur-
ia19 and elevated serum creatinine,20 yet both focused solely
on prevalent disease and neither directly examined whether
elevated uric acid levels were responsible for the effects of
soda (and HFCS) on the kidney. We therefore investigated
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whether sugar-sweetened soda consumption is associated
with hyperuricemia and kidney disease in both cross-
sectional and longitudinal analyses of data from the
Atherosclerosis Risk in Communities (ARIC) Study.
RESULTS
At the baseline ARIC visit, 15,745 participants provided
information about their regular consumption of sugar-
sweetened sodas. More than 80% of these participants
reported drinking less than one soda per day, whereas
approximately 5% drank more than one soda per day
(Table 1). Participants in the highest exposure category were
more likely to be male, African-American, and current
smokers compared with participants who drank less than one
soda per day. Participants who completed high school and
college were less likely to drink soda on a daily basis.
Although there was only a slight difference in mean body
mass index among exposure groups, participants with higher
soda consumption had significantly greater sodium, animal
protein, and total calorie intake. Hypertensive status did not
differ among exposure groups, although diabetic participants
were most represented in the group with the least amount of
sugar-sweetened soda consumption. In this generally healthy
cohort, only 4% of diabetics drank more than one regular
soda per day, whereas 16% of diabetics drank more than one
diet soda per day. The three exposure groups had essentially
equal serum creatinine measurements, but uric acid levels
were slightly higher in the groups with higher soda
consumption.
Cross-sectional analyses
Thirty-seven percent (n¼ 5790) of participants at visit 1 met
criteria for hyperuricemia; 24% (n¼ 3718) of participants
had baseline uric acids above 7.0 mg/dl. In univariate and
multivariate analyses, the odds of hyperuricemia significantly
rose with increased daily consumption of sugar-sweetened
soda (Table 2). Participants who drank less than one soda per
day were the referent in this and all subsequent analyses. The
multivariate odds ratio for hyperuricemia was 1.31
(1.12–1.53, P¼ 0.001) for participants who drank more than
one soda per day.
Of the 15,642 participants with creatinine measurements
at visit 1, 479 (3.1%) were identified as having prevalent
CKD. The odds of having prevalent CKD were not related to
the degree of soda consumption in univariate analysis, but
parsimonious and multivariate analyses suggested increased
odds of CKD with higher soda use (Table 2). The
multivariate odds ratio for prevalent CKD was 1.46
(0.96–2.22, P¼ 0.07) for participants who drank more than
one soda per day.
Logistic regression for the association of CKD and sugar-
sweetened soda consumption, using fully adjusted models
stratified by uric acid levels, suggested that the association
between soda consumption and kidney function was directly
related to uric acid levels (Table 3). The odds ratio for CKD
among participants who drank more than one soda per day
was 0.76 (0.23–2.45, P¼ 0.6) in those without hyperuricemia
and 1.50 (0.95–2.37, P¼ 0.08) in those with hyperuricemia.
The prevalence odds ratios for CKD increased with rising uric
Table 1 | Baseline characteristics of study population, stratified by sugar-sweetened soda consumption
o1 soda per day (n=12,981) 1 soda per day (n=1902) 41 soda per day (n=862)
Age 54.4 (5.8) 53.6 (5.7) 52.0 (5.5)
Female 7373 (56.8%) 919 (48.3%) 398 (46.2%)
Race
White 9882 (76.1%) 1004 (52.8%) 572 (66.4%)
Black 3056 (23.5%) 895 (47.1%) 288 (33.4%)
Other 43 (0.3%) 3 (0.2%) 2 (0.2%)
Years completed education
p11 years 2804 (21.6%) 667 (35.2%) 276 (32.1%)
12–16 years 5286 (40.8%) 738 (38.9%) 373 (43.3%)
X17 years 4872 (37.6%) 492 (25.9%) 212 (24.6%)
Current smoking 3146 (24.3%) 638 (33.6%) 333 (38.7%)
Current alcohol use 7462 (57.6%) 861 (45.4%) 441 (51.3%)
Body mass index (kg/m2) 27.6 (5.3) 28.1 (5.7) 27.9 (5.7)
Hypertensiona 4479 (34.7%) 710 (37.5%) 294 (34.3%)
Diabetesb 1604 (12.5%) 187 (10.0%) 73 (8.5%)
Caloric intake (kcal/day) 1547.0 (581.0) 1748.2 (649.2) 2010.5 (744.8)
Sodium intake (mg/day) 1456.1 (589.8) 1537.2 (610.6) 1635.0 (673.4)
Animal protein intake (g/day) 53.3 (23.7) 54.4 (23.8) 55.9 (25.1)
Serum creatinine (mg/dl) 1.1 (0.4) 1.1 (0.5) 1.1 (0.2)
Estimated GFR (ml/min per 1.73m2)c 91.2 (20.6) 94.6 (24.0) 94.1 (21.3)
Serum uric acid (mg/dl) 6.0 (1.5) 6.2 (1.6) 6.3 (1.6)
Abbreviations: ARIC, atherosclerosis risk in communities; GFR, glomerular filtration rate.
Categorical data presented as n (%); continuous data presented as mean (s.d.).
aHypertension defined as systolic blood pressure X140mmHg, diastolic blood pressure X90mmHg, or use of antihypertensive medication(s).
bDiabetes defined as previous diagnosis of diabetes, use of hypoglycemic medications, or fasting blood glucose X126mg/dl.
cEstimated glomerular filtration rate calculated from serum creatinine by the Modification of Diet in Renal Disease (MDRD) formula with calibration for ARIC creatinine values:
eGFR=186  (serum creatinine0.24)1.154 (age)0.203 1.212 (if black) 0.742 (if female).
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acid levels, from 0.28 (0.04–2.03, P¼ 0.2) in participants with
uric acid o6.0 mg/dl to 2.59 (1.18–5.71, P¼ 0.02) in
participants with uric acid levels X9.0 mg/dl.
Longitudinal analyses
Over 3 years of follow-up, 15,642 participants had uric acid
levels checked at baseline and visit 2. Of the 9451 participants
without hyperuricemia at visit 1, 3288 (34.8%) developed
hyperuricemia by visit 2. Although univariate analysis
suggested that sugar-sweetened soda intake increased the
odds of hyperuricemia, both parsimonious and multivariate
models revealed no significant association (Table 4). Parti-
cipants who drank less than one soda per day were again the
referent in all longitudinal analyses. The multivariate odds
ratio for incident hyperuricemia was 1.17 (0.95–1.43, P¼ 0.1)
among participants who drank more than one soda per day.
Multivariate linear regression, with uric acid levels as
continuous variables and comparing subjects who drank
41 soda per day to the same referent, showed no influence of
increased soda consumption on the change in uric acid level
from visit 1 to visit 2 (b coefficient 0.025, 95% CI 0.109 to
0.058).
Over 9 years of follow-up, 15,642 participants had serum
creatinine levels checked at baseline, 14,292 had repeat
levels at 3 years, and 11,559 had levels checked at 9 years.
Of the 14,002 participants without prevalent CKD at visit
1, 1160 (8.3%) met our criteria for incident CKD by visit 2
or 4. Multivariate analysis found no association between
Table 2 | Association of sugar-sweetened soda consumption with prevalent hyperuricemia and CKD
o1 soda per day
Odds ratio (95% CI)
1 soda per day
Odds ratio (95% CI)
41 soda per day
Odds ratio (95% CI)
(a) Hyperuricemia, defined by sex-specific cut points (45.7mg/dl in women, 47.0mg/dl in men)
Univariate analysis 1.00 (referent) 1.17 (1.06–1.29) 1.20 (1.04–1.38)
Parsimonious modela 1.00 (referent) 1.17 (1.06–1.29) 1.20 (1.04–1.38)
Multivariate modelb 1.00 (referent) 1.12 (1.01–1.25) 1.31 (1.12–1.53)
(b) Chronic kidney disease, defined by estimated GFRo60ml/min per 1.73m2
Univariate analysis 1.00 (referent) 0.88 (0.65–1.18) 1.02 (0.69–1.51)
Parsimonious modelc 1.00 (referent) 1.03 (0.76–1.39) 1.22 (0.81–1.83)
Multivariate modeld 1.00 (referent) 1.14 (0.84–1.55) 1.46 (0.96–2.22)
Abbreviation: GFR, glomerular filtration rate.
aChange in estimate testing for hyperuricemia suggested that univariate analysis was also the appropriate parsimonious model (i.e., no covariates, when removed from the
fully adjusted model, changed the exposure estimates by 410%).
bMultivariate model for hyperuricemia adjusted for age, sex, animal protein intake, caffeine intake, hypertension, body mass index, renal function, current tobacco and alcohol
use, ARIC field center, and race.
cChange in estimate testing for chronic kidney disease suggested a model adjusted only for diabetes, sodium intake, and the composite covariate of ARIC field center, and
race.
dMultivariate model for chronic kidney disease adjusted for age, sex, body mass index, sodium intake, caloric intake, hypertension, diabetes, current tobacco and alcohol use,
education, ARIC field center, and race.
Table 3 | Adjusted odds ratios of prevalent CKD according to sugar-sweetened soda consumption, stratified by uric acid status
o1 soda per day
Odds ratio (95% CI)a
1 soda per day
Odds ratio (95% CI)a
41 soda per day
Odds ratio (95% CI)a
Hyperuricemia, defined by sex-specific cut pointsb
Absent 1.00 (referent) 1.46 (0.81–2.60) 0.76 (0.23–2.45)
Present 1.00 (referent) 1.00 (0.69–1.44) 1.50 (0.95–2.37)
Hyperuricemia, defined as serum uric acid 47.0mg/dl
Absent 1.00 (referent) 1.17 (0.70–1.79) 0.64 (0.26–1.58)
Present 1.00 (referent) 1.15 (0.75–1.74) 1.96 (1.18–3.25)
Uric acid levels (mg/dl)
Uric acid o6.0 1.00 (referent) 1.17 (0.61–2.22) 0.28 (0.04–2.03)
6.0 puric acid o7.0 1.00 (referent) 1.08 (0.52–2.24) 0.68 (0.21–2.25)
7.0 puric acid o8.0 1.00 (referent) 0.93 (0.42–2.03) 1.31 (0.49–3.49)
8.0 puric acid o9.0 1.00 (referent) 0.82 (0.37–1.81) 1.72 (0.63–4.67)
Uric acid X9.0 1.00 (referent) 1.59 (0.82–3.10) 2.59 (1.18–5.71)
Uric acid levels (mg/dl)c
Uric acid o6.0 1.00 (referent) 1.17 (0.61–2.22) 0.28 (0.04–2.03)
6.0 puric acid o7.0 2.34 (1.71–3.20) 2.09 (1.03–4.23) 1.62 (0.50–5.21)
7.0 puric acid o8.0 3.21 (2.28–4.53) 3.18 (1.50–6.76) 4.41 (1.72–11.31)
8.0 puric acid o9.0 7.60 (5.30–10.89) 6.63 (3.06–14.39) 11.00 (4.15–29.10)
Uric acid X9.0 12.05 (8.25–17.61) 20.03 (10.57–37.95) 31.32 (15.19–64.58)
aAdjusted for age, sex, body mass index, sodium intake, caloric intake, hypertension, diabetes, current tobacco and alcohol use, education, ARIC field center, and race.
bHyperuricemia defined as serum uric acid 47.0mg/dl in men and 45.7mg/dl in women.
cAncillary analyses using a common referent group of participants with uric acid levels o6.0mg/dl and soda consumption o1 per day.
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sugar-sweetened soda consumption and odds of developing
kidney disease (Table 4). The odds ratio for incident kidney
disease was 0.82 (0.59–1.16, P¼ 0.3) among participants who
drank 41 soda per day. Sensitivity analyses excluding
diabetic participants, using a more conservative definition
of incident CKD detailed above, and using change in serum
creatinine as the outcome did not significantly change
these estimates. Multivariate linear regression evaluating
the continuous change in estimated glomerular filtration
rate (eGFR) from visit 1 to visit 2 (b coefficient 0.442,
95% CI 1.690 to 0.805) and change in eGFR from visit 1 to
visit 4 (b coefficient 0.467, 95% CI 1.990 to 1.055) were
likewise not significant for participants who consumed 41
soda per day.
As with the cross-sectional analyses, we stratified the
multivariate logistic models for the association of incident
Table 4 | Association of sugar-sweetened soda consumption with incident (a) hyperuricemia and (b) CKD
o1 soda per day 1 soda per day 41 soda per day
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
(a) Hyperuricemia, defined by sex-specific cut points (45.7mg/dl in women, 47.0mg/dl in men)
Univariate analysis 1.00 (referent) 1.23 (1.07–1.40) 1.23 (1.02–1.49)
Parsimonious modela 1.00 (referent) 1.09 (0.96–1.25) 1.17 (0.97–1.42)
Multivariate modelb 1.00 (referent) 1.11 (0.97–1.28) 1.17 (0.95–1.43)
(b) Chronic kidney disease, defined by estimated GFRo60ml/min per 1.73m2
Univariate analysis 1.00 (referent) 0.70 (0.57–0.87) 0.60 (0.43–0.83)
Parsimonious modelc 1.00 (referent) 0.77 (0.63–0.96) 0.69 (0.49–0.95)
Multivariate modeld 1.00 (referent) 0.86 (0.69–1.06) 0.82 (0.59–1.16)
Abbreviation: GFR, glomerular filtration rate.
aChange in estimate testing for hyperuricemia suggested a model adjusted only for the composite covariate of ARIC field center and race.
bMultivariate model for hyperuricemia adjusted for age, sex, caffeine intake, animal protein intake, hypertension, body mass index, renal function, current tobacco and alcohol
use, ARIC field center, and race.
cChange in estimate testing for chronic kidney disease suggested a model adjusted only for caloric intake and the composite covariate of ARIC field center and race.
dMultivariate model for chronic kidney disease adjusted for age, sex, body mass index, sodium intake, caloric intake, hypertension, diabetes, current tobacco and alcohol use,
education, ARIC field center, and race.
Table 5 | Adjusted odds ratios of incident kidney disease according to sugar-sweetened soda consumption, stratified by uric
acid status
o1 soda per day
Odds ratio (95% CI)a
1 soda per day
Odds ratio (95% CI)a
41 soda per day
Odds ratio (95% CI)a
Hyperuricemiab at visit 1
Absent 1.00 (referent) 0.68 (0.49–0.96) 0.61 (0.35–1.06)
Present 1.00 (referent) 1.03 (0.77–1.38) 1.01 (0.65–1.56)
Development of hyperuricemiab between visits 1 and 2c
Absent 1.00 (referent) 0.57 (0.35–0.94) 0.84 (0.45–1.57)
Present 1.00 (referent) 0.81 (0.50–1.31) 0.32 (0.10–1.03)
Change in uric acid levels between visits 1 and 2 (mg/dl)
D Uric acid p0.0 1.00 (referent) 1.07 (0.72–1.59) 1.34 (0.75–2.39)
0.0 oD Uric acid p1.0 1.00 (referent) 0.74 (0.51–1.08) 0.83 (0.49–1.40)
1.0 oD Uric acid p2.0 1.00 (referent) 0.74 (0.45–1.21) 0.46 (0.18–1.15)
2.0 oD Uric acid p3.0 1.00 (referent) 0.81 (0.36–1.82) 0.31 (0.04–2.43)
D Uric acid 43.0 1.00 (referent) 1.35 (0.46–4.00) 2.47 (0.41–15.07)
Uric acid levels at visit 1 (mg/dl)
Uric acid o6.0 1.00 (referent) 0.63 (0.43–0.92) 0.63 (0.35–1.14)
6.0 pUric acid o7.0 1.00 (referent) 1.00 (0.65–1.53) 0.57 (0.26–1.25)
7.0 pUric acid o8.0 1.00 (referent) 1.33 (0.83–2.12) 0.74 (0.33–1.68)
8.0 pUric acid o9.0 1.00 (referent) 0.87 (0.44–1.69) 0.72 (0.25–2.12)
Uric acid X9.0 1.00 (referent) 0.57 (0.19–1.73) 3.90 (1.55–9.82)
Uric acid levels at visit 1 (mg/dl)d
Uric acid o6.0 1.00 (referent) 0.63 (0.43–0.92) 0.63 (0.35–1.14)
6.0 pUric acid o7.0 1.30 (1.09–1.55) 1.32 (0.88–1.98) 0.72 (0.33–1.55)
7.0 pUric acid o8.0 1.62 (1.31–1.99) 2.00 (1.29–3.09) 1.25 (0.57–2.75)
8.0 pUric acid o9.0 2.06 (1.58–2.68) 1.84 (0.98–3.44) 1.50 (0.53–4.27)
Uric acid X9.0 1.87 (1.34–2.62) 0.97 (0.34–2.73) 5.72 (2.64–12.36)
aAdjusted for age, sex, body mass index, sodium intake, caloric intake, hypertension, diabetes, current tobacco and alcohol use, education, ARIC field center, and race.
bHyperuricemia defined as serum uric acid 47.0mg/dl in men and 45.7mg/dl in women.
cAnalysis excludes participants with hyperuricemia at visit 1.
dAncillary analyses using a common referent group of participants with uric acid levels o6.0mg/dl and soda consumption o1 per day.
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CKD and soda consumption by uric acid levels (Table 5).
Neither the presence of hyperuricemia at visit 1 nor the
development of hyperuricemia between visits 1 and 2
increased the odds of developing CKD among high-soda
consumers in this cohort. Likewise, no degree of change in
uric acid levels between visits 1 and 2 seemed to modify the
lack of association between soda consumption and incident
CKD during the study period. Only participants with uric
acid levels of 9.0 mg/dl or higher at visit 1 showed an
increased odds of developing CKD if they drank more than
one soda per day (OR 3.90, 95% CI 1.55–9.82) compared to
participants with similar uric acid elevations who drank less
than one soda per day.
Diet soda consumption
We repeated our analyses substituting diet soda intake as the
exposure of interest and using the same three categories of
exposure (that is, participants who drank o1 diet soda per
day were the referent category). In multivariate models,
consumption of 41 diet soda was not associated with
prevalent hyperuricemia (OR 1.10, 95% CI 0.98–1.24),
prevalent CKD (OR 1.29, 95% CI 0.95–1.74), incident
hyperuricemia (OR 0.97, 95% CI 0.83–1.14), or incident
CKD (OR 0.80, 95% CI 0.64–1.00) (Supplementary Table S1).
Multivariate linear regression comparing subjects who drank
41 diet soda per day to those who drank o1 diet soda per
day similarly showed no influence of increased diet soda
consumption on the change in uric acid level from visit 1 to
visit 2 (b coefficient 0.024, 95% CI 0.039 to 0.087), change
in eGFR from visit 1 to visit 2 (b coefficient 0.380, 95% CI
1.313 to 0.553), or change in eGFR from visit 1 to visit 4 (b
coefficient 0.184, 95% CI 1.319 to 0.950). Finally, in
stratified analysis, subjects with baseline uric acid levels
X9.0 mg/dl who drank 41 diet soda per day did not have
increased odds of either prevalent CKD (OR 0.71, 95% CI
0.28–1.83) or incident CKD (OR 0.44, 95% CI 0.12–1.52).
DISCUSSION
In this study, increased consumption of regular soft drinks
was associated with prevalent hyperuricemia and CKD.
Stratified analysis also suggested that the association between
such sweetened beverages and kidney function was primarily
among participants with elevated uric acid levels. However,
in longitudinal analyses, these associations did not hold.
These findings present new but conflicting evidence as to
whether sugar-sweetened sodas, and potentially the HFCS
used to sweeten them, are a dietary risk factor for
development of hyperuricemia and CKD.
The results of this study complement a growing body of
literature tying sugar-sweetened soda consumption to higher
rates of chronic diseases such as obesity, hypertension, and
diabetes.21–23 Our findings are consistent with previously
published reports in which high sugar-sweetened soda
consumption was associated with prevalent hyperuricemia
and renal injury.4,19,20 Yet this study, to the best of our
knowledge, is the first to examine whether sugar-sweetened
soda consumption is associated with incident forms of these
diseases. The results of these incidence analyses add an
important note of caution to the literature on sugar-
sweetened soda and HFCS. Although the cross-sectional
analyses performed in this and other studies4,19 support a
hypothesis that increased HFCS-sweetened soda consump-
tion leads to higher uric acid levels that in turn induce renal
damage, the longitudinal analyses do not support this theory.
Indeed, the associations shown in our cross-sectional
analyses must be viewed in context of the lack of association
in our longitudinal analyses, which arguably would provide
stronger evidence for a causative role if they were sufficiently
powered and free of bias. Post hoc power analyses showed that
we had 480% power to detect a 6.5% higher incidence of
hyperuricemia and a 3% higher incidence of CKD in
participants who drank 41 soda per day compared with
participants who drank o1 soda per day. Therefore, if the
proposed causal link between sugar-sweetened soda con-
sumption, hyperuricemia, and CKD that is suggested by ours
and others’ cross-sectional analyses is real, we must explore
the lack of association between soda consumption and
incident disease in this cohort. We suggest four possible
explanations.
First, the duration of sugar-sweetened soda exposure may
be important. The mean follow-up in this cohort was
approximately 9 years, and a longer exposure period may be
needed to produce incident disease. This interpretation,
admittedly, does not support a role for HFCS in the
prevalence data, as the participants at visit 1 (1987–1989)
would have likely had an even shorter exposure period to
HFCS, which was only widely introduced in the early 1980s.
Second, it is conceivable that enrollment in this study may
have led to an improvement in general health behaviors that
modified soda consumption over the course of the study
period. Our sensitivity analysis of participants who reported
high intake of soda at both visits 1 and 3, however, showed
lower point estimates for the odds of developing new
hyperuricemia or CKD. The third, and in our opinion most
plausible, explanation is the role of survival bias in this type
of analysis. Participants who had not yet developed
hyperuricemia or CKD by the time of the initial ARIC visit,
when mean age was 54.2 years, may have some unidentified
protective factor making them less likely to develop either of
these conditions in later years. If sugar-sweetened soda
consumption truly elevated uric acid levels and/or reduced
kidney function, it may be unlikely for this effect to first
manifest after the age 50. Theoretically, a modern cohort of
younger subjects with a longer duration of follow-up might
yield different results from those presented here. Finally, as
with all such observational studies, unmeasured confounding
may have influenced the cross-sectional and/or longitudinal
analyses.
This study has a number of limitations. Our exposure of
interest is based on participants’ dietary recall, and measure-
ment error is inevitable. However, when compared to values
from the typical American diet, values for daily sodium,
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protein, and caloric intake reported by these participants
(Table 1) suggest underreporting across all exposure
categories that should bias estimates toward the null if
such misclassification is assumed to be nondifferential.24
Conversely, as sodium intake has previously been shown to
be higher in individuals with heavy regular soda consump-
tion,21 misclassification for this covariable may not be
entirely random. Repeated-measures sensitivity analyses
using dietary data from both visits 1 and 3 produced similar
point estimates for our outcomes of interest, and multivariate
models using a five-level category of exposure were consistent
with our main models (Supplementary Table S2). We did not
have detailed information on participants’ medications and
therefore were unable to adjust for use of drugs that could
affect uric acid (for example, diuretics) or creatinine (for
example, ACE inhibitors or ARBs) measurements. Similarly,
we lacked data regarding heavy metal exposure that could
also have affected uric acid and creatinine levels.
Like most epidemiologic studies of CKD, our definition of
CKD is based on a limited number of isolated creatinine
measurements that were not repeated within 3 months to
confirm a chronic reduction in GFR.25 Nevertheless, the 3%
prevalence and 8% incidence rates of CKD in this cohort are
quite low when compared to national data (approximately
7% prevalence of eGFRo60 ml/min per 1.73 m2 among all
US adults),26 particularly given the age of ARIC participants.
The probable underdiagnosis of CKD in this cohort, if
anything, biased our results again toward the null. Further-
more, sensitivity analyses using a more conservative defini-
tion of incident CKD and defining incident CKD by
continuous changes in serum creatinine and eGFR produced
similar results. Further, ancillary ARIC data on urinary
albumin excretion from visit 4 found no association between
increased soda consumption and either micro- or macro-
albuminuria (Supplementary Table S3). The prevalence and
incidence rates of hyperuricemia in this study were slightly
higher than the national average (18% prevalence rate for all
US adults),4 but this is likely explained by the age of ARIC
participants as our data concur with the prevalence of
hyperuricemia published in a large middle-aged cohort in
which the baseline prevalence approached 50%.5
Finally, our results strictly pertain to the intake of sugar-
sweetened sodas in a generally healthy cohort; for these
individuals, sugar-sweetened sodas were not associated with
incident hyperuricemia and kidney disease. These findings do
not justify unbridled consumption of sugar-sweetened sodas
by individuals with and without CKD. Rather, our study is an
important addition to the large and still-growing body of
literature surrounding the potential health consequences of
sugar-sweetened soda, which is based principally on observa-
tional studies such as this one.12–15 Our ‘negative’ study
results—subject to the same potential sources of error (bias,
chance, confounding) as others’ ‘positive’ study results—
should be used to further inform, rather than end, the heated
debate regarding this important public health issue. In
addition, this study should not be interpreted as suggesting
that uric acid does not have a role in the development of
kidney injury and CKD, as shown in recent studies.5–8 This
study is similar to the recently published study by Forman
et al. that found no association between fructose intake and
the risk for incident hypertension over 14–20 years of follow-
up27 despite substantial evidence that elevated uric acid levels
increase the risk for developing hypertension.28–33 In fact, in
both our cross-sectional and longitudinal studies, increased
consumption of sugar-sweetened sodas in the presence of
very elevated uric acid levels (X9.0 mg/dl) did appear to
influence development of kidney disease, although only 812
subjects had uric acid levels X9 mg/dl at the baseline visit,
and only 64 (8%) drank more than one soda per day, so
caution should be used when interpreting the results.
In this large biracial cohort, high consumption of sugar-
sweetened sodas appeared to be associated with prevalent
hyperuricemia and CKD. In stratified analysis, the association
between soda and kidney function became more pronounced
as uric acid levels increased. However, similar associations
were not seen in longitudinal analyses of incident hyperur-
icemia and CKD. Therefore, our findings add to but in no
way close the heated discussion over the potential dangers of
sugar-sweetened soda.12,13,15–17,33,34
MATERIALS AND METHODS
Participants and study design
Data were obtained from the ARIC Study, a prospective
biracial observational cohort assembled from four field
centers in Jackson, Mississippi; Forsyth County, North
Carolina; suburban Minneapolis, Minnesota; and Washington
County, Maryland. A full description of ARIC is available
elsewhere.35 A total of 15,792 participants, men and women
aged 45–64 years, were enrolled at the baseline visit (visit 1)
between 1987 and 1989. Three follow-up visits occurred
approximately every 3 years at community-based clinics. In
addition to physical examinations and laboratory studies at
each visit, surveys were also administered to each participant
to obtain demographic data, medical history, and social
habits. Included in these surveys were detailed food
frequency questionnaires (FFQs) for dietary intake data.
This study uses laboratory and questionnaire data from visits
1, 2, 3, and 4. The ARIC protocol was approved by the
institutional review boards of all participating centers.
Informed consent was obtained from all participants.
Outcomes
The outcomes of interest were prevalent and incident
hyperuricemia and CKD. Serum uric acid (mg/dl) was
evaluated at the first and second visits. We defined
hyperuricemia using sex-specific cut points of 45.7 mg/dl
in women and 47.0 mg/dl in men as suggested by the
literature.4,36–38 For sensitivity analyses, we used a gender-
neutral definition of hyperuricemia as 47.0 mg/dl. We also
divided participants into five categories of uric acid levels at
visit 1 (o6.0, 6.0–6.9, 7.0–7.9, 8.0–8.9, and 49.0 mg/dl) and
changes in uric acid levels between visits 1 and 2 (p0.0,
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0.1–1.0, 1.1–2.0, 2.1–3.0, and 43.0 mg/dl) for stratified
analyses of our CKD outcomes.
Kidney function was evaluated at the first, second, and
fourth visits by serum creatinine (mg/dl). We calculated
eGFR using the Modification of Diet in Renal Disease
formula.39 ARIC creatinines were calibrated by subtracting
0.24 mg/dl at visits 1 and 2 and adding 0.18 mg/dl at visit 4,
as published elsewhere.5 Consistent with current guidelines
on classifying CKD,25 we defined prevalent CKD as a baseline
eGFR o60 ml/min per 1.73 m2. For analyses of incident
CKD, we excluded all participants with eGFR o60 ml/min
per 1.73 m2 at visit 1, and, for the remaining participants, we
defined incident CKD as eGFR o60 ml/min per 1.73 m2 at
visits 2 and 4, at visit 2 with missing data at visit 4, at visit 4
with missing data at visit 2, and at visit 4 alone. For
sensitivity analyses, we used a conservative definition of
incident CKD that included only those participants with
complete data at visits 1, 2, and 4 whose eGFR dropped from
X60 ml/min per 1.73 m2 at visit 1 to o60 ml/min per
1.73 m2 at visits 2 and 4, as well as a definition for incident
kidney disease based on change in serum creatinine
(40.4 mg/dl or 4150% increase).
Predictors
At ARIC visits 1 and 3, participants completed a 66-item
semiquantitative FFQ developed and validated by Willett
et al.40 Sugar-sweetened soda consumption was determined
from FFQs administered at visit 1, using data from the
question on ‘regular soft drinks, such as Coke, Pepsi, 7Up,
Ginger Ale.’ As mentioned in the introduction, the HFCS
used to sweeten these soft drinks is typicallyp55% fructose,
the other components being glucose and readily hydrolyzable
polymers of glucose. Participants were allowed nine potential
responses (in glasses): almost never, 1–3 per month, 1 per
week, 2–4 per week, 5–6 per week, 1 per day, 2–3 per day, 4–6
per day, and 46 per day. We collapsed these responses into
three levels: less than one soda per day, one soda per day, and
more than one soda per day. We chose this categorization
scheme to capture significant degrees of exposure with easily
communicable levels of beverage intake. We used the same
three-category exposure scheme to evaluate whether diet
soda intake (assessed in a virtually identical question on the
dietary survey) was associated with our outcomes of interest.
In sensitivity analyses, we also used a five-level exposure
category for soda consumption: almost never, no more than
one soda per week, 2–6 sodas per week, one soda per day, and
more than one soda per day. Finally, dietary data from visit 3
of the study were included in sensitivity analyses of the
longitudinal studies using the highest exposure category from
either visit 1 or 3 and the mean of data from both FFQs.
Other baseline characteristics included demographics,
lifestyle and dietary characteristics, medical history, and
physical examination findings. A composite variable for race
and field center was used given that approximately 90% of
the African-American participants were enrolled at the
Jackson site. Tobacco and alcohol were dichotomized by
current use. Diabetes was defined by medication use or
fasting glucose level X126 mg/dl. Hypertension was defined
by systolic pressure X140 mm Hg, diastolic pressure
X90 mm Hg, or use of antihypertensive medication. Daily
nutrient intakes were derived from the baseline FFQ
responses using the Harvard nutrient database.
Statistical analyses
Prevalence odds ratios were obtained using univariate and
multivariate logistic regression. Logistic regression was also
used to assess the relationship between baseline soda
consumption, incident hyperuricemia, and incident CKD
because we could not determine specific time points at which
an individual met our criteria for hyperuricemia or CKD. We
used proportional hazards models for secondary analyses of
both prevalent and incident outcomes (for prevalent out-
comes, we set a constant time interval,41 and for incident
outcomes, we set the time interval to be the halfway point
between visit 1 and the visit at which CKD or hyperuricemia
were first identified). To isolate the potential effects of HFCS,
we performed parallel analyses using diet soda, instead of
regular soft drinks, as the main exposure. Because hyperur-
icemia was felt to be a causal intermediate in the association
of sugar-sweetened soda consumption and CKD, we analyzed
these outcomes separately and in stratified analyses.
Potential covariates for each outcome were based on
directed acyclic graphs42 and included age, sex, animal
protein intake, sodium intake, caloric intake, caffeine intake,
education, diabetic status, hypertensive status, body mass
index, renal function, current tobacco and alcohol use, ARIC
field center, and race. All covariates were treated as
continuous variables when appropriate. We evaluated
effect-measure modification by each covariate using like-
lihood ratio tests that compared models with and without
interaction terms. A conservative P-value of 0.15 for such
tests of interaction identified no important interactions; by
choosing Po0.15 as the threshold, we reduced the risk of a
type II error (that is, a false negative for the test of
interaction). After univariate analysis, a parsimonious
adjusted model was constructed using change-in-estimate
testing for each covariate against a full model that included
all directed acyclic graph-identified covariates. The parsimo-
nious models included only those covariates that, when
removed from the fully adjusted model, changed the
exposure estimates byX10%. Finally, we performed analyses
for full models that included all covariates, regardless of
significance testing, that were identified as potential con-
founders by the directed acyclic graphs.
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